AI summary Trust: medium Third-party lab

LabE tested this tirzepatide batch (January 2, 2026) at 99.9% purity via HPLC. The tested quantity of 24.7mg significantly exceeded the 20mg label by 23.5%. Endotoxin status is not available, and the test is recent (under 3 months). Customers can cross-check on the lab's public verification URL.

Watch out for
  • no endotoxin test
  • quantity deviation (23.5%)
Test date
2026-03-06
Purity
99.90% 99.90%
Batch / lot
January 2, 2026
Lab
LabE
Quantity
label 20mg tested 24.7mg
Qty vs label
+23.5%
Endotoxins
n/a
Test score
7.0
Manufacturer
Shandong Aishi Biotechnology
View vendor dossier
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Finnrick

✓ Artifact captured

We have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact below.

Verify on upstream
Method
HPLC + mass quantification + endotoxins
Test type
finnrick_composite
Dose
20mg
Container
No Label / Silver Crimp / Violet Cap
Catalogued
2026-04-16
Artifact hash
73d2857a064b88e3…
This COA is part of TitrateLab's community-trust corpus. See more from Shandong Aishi Biotechnology or learn how trust scores are computed on the methodology page.